Compare Cronos Group Inc (CRON) vs Williams-Sonoma, Inc. (WSM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Williams-Sonoma, Inc. — how do they compare? Cronos Group Inc trades at $2.75 (market cap $1.02B), while Williams-Sonoma, Inc. trades at $222.5 (market cap $25.51B). The key difference: Williams-Sonoma, Inc. is far larger — about 25× Cronos Group Inc's market cap, and Williams-Sonoma, Inc. pays a 1.4% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.
| CRON | WSM | |
|---|---|---|
Market Cap | $1.02B | $25.51B |
Sector | Health | Consumer Cyclical |
52-Week High | $3.27 | $240.06 |
52-Week Low | $1.95 | $163.62 |
Enterprise Value | $203.29M | $26.35B |
Dividend Yield | — | 1.4% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $2.75, showing no change recently. The stock has a mixed technical outlook with a neutral overall signal but bullish moving averages. Fundamentally, revenue grew to $146.59M in 2025, but net income was negative at -$9.45M. Recent news highlights strong Q1 2026 revenue growth of 40% and expansion of its Spinach brand portfolio, though the company faces intense cannabis sector competition.
Outlook is cautious with growth potential from international expansion and market share gains, but profitability remains a challenge. Risks include regulatory uncertainty and competitive pressures. Analyst sentiment is mixed with 60% hold ratings. The stock presents a speculative opportunity for investors betting on continued top-line growth and eventual margin improvement.
Williams-Sonoma (WSM) trades at $216.65, down 2.3% on the day, with a bullish technical outlook supported by moving averages but mixed oscillators. The company demonstrates strong profitability with a 13.81% net margin and 54.01% ROE, though revenue has declined slightly from $8.7B in 2023 to $7.7B in 2025. Recent quarterly earnings have consistently beaten estimates, and the company maintains active brand collaborations and dividend payments.
The stock presents a balanced outlook with solid fundamentals and analyst consensus near the current price, but faces risks from revenue volatility and competitive pressures. Upside potential exists if earnings momentum continues, while macroeconomic headwinds and retail sector challenges pose downside risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Williams-Sonoma, Inc.
With a wide retail and direct-to-consumer presence, Williams-Sonoma is a leader in the $300 billion domestic home category, focused on expanding its exposure in the B2B, marketplace, and franchise areas. Namesake Williams-Sonoma (175 stores) offers high-end cooking essentials, while Pottery Barn (189) provides casual home accessories. Brand extensions include Pottery Barn Kids (52) and PBteen. West Elm (121) is an emerging concept for young professionals, and Rejuvenation (9) offers lighting and house parts. Williams-Sonoma also has a business-to-business team that supports projects that range from residential to large-scale commercial.
Read more on WSM →
